Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Researchers at a university are exploring how endometriosis could influence the development of ovarian cancer and lead to ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other ...

A cancer cell (nucleus in blue, cellular ‘skeleton’ in green). Scientists have devised nanosensors that can measure the ...